CFTR and cystic fibrosis: The types of adverse events reported generally aligned with what has been observed in clinical trials. It is necessary to monitor these effects in people with CF on CFTR modulators in the real-world setting to help better understand potential adverse events and patient characteristics that may be associated with a higher risk of specific adverse events.